DTU
DTU

A Diabetes Outcomes Progression Trial

Conference abstracts (21 of 21)

Years :

Search conference abstracts :

2007

43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam
Increased incidence of fractures in women who received rosiglitazone in ADOPT (A Diabetes Outcome Progression Trial)
Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group
Diabetologia 2007;50:Suppl 1:S37
[Abstract]

43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam
Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain
Haffner SM, Kahn SE, Zinman B, Holman R, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007;50:Suppl 1:S36
[Abstract]

43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam
Determinants of monotherapy failure in ADOPT (A Diabetes Outcome Progression Trial)
Holman RR, Kahn SE, S. Haffner M, Zinman B, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007;50:Suppl 1:S356
[Abstract]

43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam
ADOPT: The effectiveness of metformin versus glyburide in type 2 diabetes
Herman WH, Haffner SM, Kahn SE, Zinman B, Holman RR, Viberti GF, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007;50:Suppl 1:S362
[Abstract]

2005

41st Annual Meeting of the European Association for the Study of Diabetes, Athens
Obesity is a major determinant of the association of C-reactive protein levels with the number of metabolic syndrome components in recently diagnosed, drug-naive type 2 diabetes: the ADOPT study cohort
Kahn SE, Zinman B, Viberti G, Kravitz BG, Yu D, Heise MA, Freed MI, the ADOPT Study Group
Diabetologia 2005;48:suppl 1:A249
[Abstract]

41st Annual Meeting of the European Association for the Study of Diabetes, Athens
BMI and ratio of triglycerides to HDL are most predictive of insulin resistance in a drug naive population with type 2 diabetes
Patwardhan R, Lin X, Zambanini A, Eslava S, the ADOPT Study Group
Diabetologia 2005;48:suppl 1:A222
[Abstract]

65th Scientific Sessions of the American Diabetes Association, San Diego
Hepatic enzymes are associated with insulin resistance and impaired fibrinolysis in drug naïve, recently diagnosed type 2 diabetes subjects
Haffner SM, Kahn SE, Heise MA, O'Neill MC, Zinman B, the ADOPT Study Group
Diabetes 2005;54:suppl 1:A255
[Abstract]

65th Scientific Sessions of the American Diabetes Association, San Diego
Obesity is a major determinant of the association of C-reactive protein levels with the number of metabolic syndrome components in type 2 diabetes
Kahn SE, Zinman B, Viberti G, Kravitz BG, Yu D, Heise MA, Freed MI, the ADOPT Study Group
Diabetes 2005;54:suppl 1:A255
[Abstract]

2003

18th International Diabetes Federation Congress, Paris
Estimations of the clinical benefit of optimal blood glucose, blood pressure and lipid control in type 2 diabetic patients with the metabolic syndrome
Koro CE, Bowlin S, Sun Y, Gomez-Camineros A, the ADOPT Study Group
Diabetologia 2003;46:Suppl 2:A76
[Abstract]

18th International Diabetes Federation Congress, Paris
Differences in the prevalence of the metabolic syndrome between ethnic groups in recently diagnosed type 2 diabetes in the North American cohort of the ADOPT study
Haffner SM, Zinman B, Kahn SE, Herman WH, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A144
[Abstract]

18th International Diabetes Federation Congress, Paris
Symptoms and health status in a recently-diagnosed type 2 diabetic population: the ADOPT study
Perry A, Herman W, Freed MI, Heise MA, Kravitz B, the ADOPT Study Group
Diabetes Metabolism 2003;29:4S16-4S17
[Abstract]

18th International Diabetes Federation Congress, Paris
Are different clinical practice guidelines associated with regional differences in diabetes care?
Herman WH, Kravitz B, Sun Y, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A436
[Abstract]

18th International Diabetes Federation Congress, Paris
Prevalence and clinical significance of glutamic acid decarboxylase (GAD) antibodies in recently diagnosed type 2 diabetes in the ADOPT study cohort.
Zinman B, Kahn SE, Haffner SM, Herman W, Heise MA, O'Neill MC, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A148
[Abstract]

18th International Diabetes Federation Congress, Paris
Prevalence of microalbuminuria in recently diagnosed type 2 diabetes mellitus and its relationship to non-traditional risk factors: observations from the ADOPT study
Viberti G, Freed MI, Holman R, Lachin J, Heise MA, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A326
[Abstract]

18th International Diabetes Federation Congress, Paris
Lack of concordance of WHO and NCEP criteria for the diagnosis of the metabolic syndrome in recently diagnosed diabetes in North America and Europe in the ADOPT study cohort
Kahn SE, Haffner SM, Zinman B, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group
Diabetes Metabolism 2003;29:4S32
[Abstract]

18th International Diabetes Federation Congress, Paris
Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study
Holman RR, Kahn SE, Heise MA, Porter LE, Freed MI, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A198
[Abstract]

63rd Scientific Sessions of the American Diabetes Association, New Orleans
Ethnic differences in the prevalence of the metabolic syndrome in recently diagnosed type 2 diabetes in the North American cohort of the ADOPT study
Haffner SM, Zinman B, Kahn SE, Herman WH, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group
Diabetes 2003;52:suppl:A220
[Abstract]

63rd Scientific Sessions of the American Diabetes Association, New Orleans
Lack of concordance of NCEP and WHO criteria for the diagnosis of the metabolic syndrome in recently diagnosed diabetes in North America and Europe in the ADOPT study cohort
Kahn SE, Haffner SM, Zinman B, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group
Diabetes 2003;52:suppl:A222
[Abstract]

63rd Scientific Sessions of the American Diabetes Association, New Orleans
Prevalence of microalbuminuria and its relationship to non-traditional risk factors in recently diagnosed type 2 diabetes mellitus: observations from the ADOPT study
Viberti G, Freed MI, Holman R, Lachin J, Heise MA, the ADOPT Study Group
Diabetes 2003;52:suppl:A190
[Abstract]

63rd Scientific Sessions of the American Diabetes Association, New Orleans
Prevalence and clinical significance of glutamic acid decarboxylase (GAD) antibodies in recently diagnosed type 2 diabetes in the ADOPT study cohort
Zinman B, Kahn SE, Haffner SM, Herman W, Heise MA, O'Neill MC, the ADOPT Study Group
Diabetes 2003;52:suppl:A233
[Abstract]

63rd Scientific Sessions of the American Diabetes Association, New Orleans
The ADOPT study: symptoms and health status in a recently diagnosed type 2 diabetic population
Herman W, Freed MI, Heise MA, Kravitz B, Perry A, the ADOPT Study Group
Diabetes 2003;52:suppl:A263
[Abstract]